1,3-ditolylguanidine has been researched along with Torticollis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, K; Kuroda, S; Okumura, K; Ujike, H | 1 |
Higuchi, H; Sato, K; Shimizu, T; Takahashi, H; Yoshida, K | 1 |
Bartolini, A; Galeotti, N; Ghelardini, C | 1 |
3 other study(ies) available for 1,3-ditolylguanidine and Torticollis
Article | Year |
---|---|
BMY-14802 reversed the sigma receptor agonist-induced neck dystonia in rats.
Topics: Animals; Antipsychotic Agents; Dibenzothiepins; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dystonia; Guanidines; Haloperidol; Male; Microinjections; Nerve Tissue Proteins; Perphenazine; Piperidines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, sigma; Red Nucleus; Sulpiride; Torticollis | 1996 |
Biperiden hydrochlorate ameliorates dystonia of rats produced by microinjection of sigma ligands into the red nucleus.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Biperiden; Disease Models, Animal; Guanidines; Haloperidol; Male; Muscarinic Antagonists; Neuroleptic Malignant Syndrome; Rats; Rats, Wistar; Receptors, sigma; Red Nucleus; Torticollis | 2000 |
Pharmacological identification of SM-21, the novel sigma(2) antagonist.
Topics: Analgesics; Animals; Anticonvulsants; Butyrates; Guanidines; Male; Rats; Rats, Wistar; Receptors, sigma; Red Nucleus; Torticollis; Tropanes | 2000 |